Phase II trial − Weekly Taxotere [docetaxel] and topotecan for recurrent ovarian, primary peritoneal, endometrial and uterine cancers.
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2012
At a glance
- Drugs Docetaxel; Topotecan
- Indications Endometrial cancer; Ovarian cancer; Peritoneal cancer; Uterine cancer
- Focus Therapeutic Use
- 13 Nov 2005 New trial record.